Changes

Jump to: navigation, search

Wind Energy

44,622 bytes removed, 06:23, 14 March 2011
/* Control patents */
| Doubly-controlled asynchronous generator
|}
 
<p>==test==
</p>
<p> <style>body, div, table, thead, tbody, tfoot, tr, th, td, p { font-family: "Sans"; font-size: x-small; }</style>
<table rules="NONE" border="0" cellspacing="0" cols="7" frame="VOID"> <colgroup><col width="144"><col width="98"><col width="91"><col width="99"><col width="97"><col width="104"><col width="215"></colgroup> <tbody>
<tr>
<td style="border: 1px solid rgb(0, 0, 0);" colspan="7" align="CENTER" bgcolor="#99ccff" height="42" valign="MIDDLE" width="848"><strong><font color="#000000">IPC &amp; ECLA CLASS codes and definitions </font></strong></td>
</tr>
<tr>
<td style="border: 1px solid rgb(0, 0, 0);" align="CENTER" bgcolor="#99ccff" height="62" valign="MIDDLE"><font color="#000000"><a href="http://www.wipo.int/ipcpub/#refresh=symbol&amp;notion=scheme&amp;version=20110101&amp;symbol=A61K">A 61</a></font></td>
<td style="border: 1px solid rgb(0, 0, 0);" colspan="6" align="CENTER" bgcolor="#99ccff" valign="MIDDLE"><font color="#000000">MEDICAL OR VETERINARY SCIENCE; HYGIENE</font></td>
</tr>
<tr>
<td style="border: 1px solid rgb(0, 0, 0);" align="CENTER" bgcolor="#ffffff" height="33" valign="MIDDLE"><font color="#000000">
<br /></font></td>
<td style="border: 1px solid rgb(0, 0, 0);" align="CENTER" bgcolor="#ffffff" valign="MIDDLE"><font color="#000000"><a href="http://www.wipo.int/ipcpub/#refresh=page&amp;notion=scheme&amp;version=20110101&amp;symbol=A61P&amp;lang=fr">A 61P</a></font></td>
<td style="border: 1px solid rgb(0, 0, 0);" colspan="5" align="CENTER" bgcolor="#ffffff" valign="TOP"><font color="#000000">SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS</font></td>
</tr>
<tr>
<td style="border: 1px solid rgb(0, 0, 0);" align="CENTER" height="18" valign="MIDDLE"><font color="#000000">
<br /></font></td>
<td style="border: 1px solid rgb(0, 0, 0);" align="CENTER" valign="MIDDLE"><font color="#000000">
<br /></font></td>
<td style="border: 1px solid rgb(0, 0, 0);" align="CENTER" bgcolor="#ffffff" valign="MIDDLE"><font color="#000000"><a href="http://www.wipo.int/ipcpub/#refresh=symbol&amp;notion=scheme&amp;version=20110101&amp;symbol=A61P0017000000&amp;lang=fr"> 17/00</a></font></td>
<td style="border: 1px solid rgb(0, 0, 0);" colspan="4" align="LEFT" valign="TOP"><font color="#000000">Drugs for dermatological disorders</font></td>
</tr>
<tr>
<td style="border: 1px solid rgb(0, 0, 0);" align="CENTER" height="35" valign="MIDDLE"><font color="#000000">
<br /></font></td>
<td style="border: 1px solid rgb(0, 0, 0);" align="CENTER" valign="MIDDLE"><font color="#000000">
<br /></font></td>
<td style="border: 1px solid rgb(0, 0, 0);" align="CENTER" bgcolor="#ffffff" valign="MIDDLE"><font color="#000000">
<br /></font></td>
<td style="border: 1px solid rgb(0, 0, 0);" align="CENTER" valign="MIDDLE"><font color="#000000"><a href="http://www.wipo.int/ipcpub/#lang=en&amp;symbol=A61P0017140000&amp;refresh=page">17/14</a></font></td>
<td style="border: 1px solid rgb(0, 0, 0);" colspan="3" align="LEFT" valign="TOP"><font color="#000000">for baldness or alopecia</font></td>
</tr>
<tr>
<td style="border: 1px solid rgb(0, 0, 0);" align="CENTER" height="18" valign="MIDDLE"><font color="#000000">
<br /></font></td>
<td style="border: 1px solid rgb(0, 0, 0);" align="CENTER" valign="MIDDLE"><font color="#000000">
<br /></font></td>
<td style="border: 1px solid rgb(0, 0, 0);" align="CENTER"><font color="#000000"><a href="http://www.wipo.int/ipcpub/#lang=en&amp;symbol=A61P0009080000&amp;refresh=symbol&amp;notion=scheme&amp;version=20110101">09/08</a></font></td>
<td style="border: 1px solid rgb(0, 0, 0);" colspan="4" align="CENTER" valign="MIDDLE"><font color="#000000">Vasodilators for multiple indications</font></td>
</tr>
<tr>
<td style="border: 1px solid rgb(0, 0, 0);" align="CENTER" height="35" valign="MIDDLE"><font color="#000000">
<br /></font></td>
<td style="border: 1px solid rgb(0, 0, 0);" align="CENTER" bgcolor="#ffffff" valign="MIDDLE"><font color="#000000">
<br /></font></td>
<td style="border: 1px solid rgb(0, 0, 0);" align="CENTER" bgcolor="#ffffff"><font color="#000000"><a href="http://www.wipo.int/ipcpub/#lang=en&amp;symbol=A61P0009100000&amp;refresh=symbol&amp;notion=scheme&amp;version=20110101">09/10</a></font></td>
<td style="border: 1px solid rgb(0, 0, 0);" colspan="4" align="CENTER" valign="MIDDLE"><font color="#000000">for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis </font></td>
</tr>
<tr>
<td style="border: 1px solid rgb(0, 0, 0);" align="CENTER" height="18"><font color="#000000">
<br /></font></td>
<td style="border: 1px solid rgb(0, 0, 0);" align="CENTER"><font color="#000000"><a href="http://www.wipo.int/ipcpub/#refresh=page&amp;notion=scheme&amp;version=20110101&amp;symbol=A61Q&amp;lang=fr">A61Q</a></font></td>
<td style="border: 1px solid rgb(0, 0, 0);" colspan="5" align="CENTER"><font color="#000000">SPECIFIC USE OF COSMETICS OR SIMILAR TOILET PREPARATIONS</font></td>
</tr>
<tr>
<td style="border: 1px solid rgb(0, 0, 0);" align="CENTER" height="35"><font color="#000000">
<br /></font></td>
<td style="border: 1px solid rgb(0, 0, 0);" align="CENTER"><font color="#000000">
<br /></font></td>
<td style="border: 1px solid rgb(0, 0, 0);" align="CENTER"><font color="#000000"><a href="http://www.wipo.int/ipcpub/#refresh=symbol&amp;notion=scheme&amp;version=20110101&amp;symbol=A61Q0005000000&amp;lang=fr">05/00</a></font></td>
<td style="border: 1px solid rgb(0, 0, 0);" colspan="4" align="LEFT" valign="TOP"><font color="#000000">Preparations for care of the hair</font></td>
</tr>
<tr>
<td style="border: 1px solid rgb(0, 0, 0);" align="CENTER" height="35"><font color="#000000">
<br /></font></td>
<td style="border: 1px solid rgb(0, 0, 0);" align="CENTER"><font color="#000000">
<br /></font></td>
<td style="border: 1px solid rgb(0, 0, 0);" align="CENTER"><font color="#000000"><a href="http://www.wipo.int/ipcpub/#refresh=symbol&amp;notion=scheme&amp;version=20110101&amp;symbol=A61Q0007000000&amp;lang=fr">07/00</a></font></td>
<td style="border: 1px solid rgb(0, 0, 0);" colspan="4" align="LEFT" valign="TOP"><font color="#000000">Preparations for affecting hair growth </font></td>
</tr>
<tr>
<td style="border: 1px solid rgb(0, 0, 0);" align="CENTER" height="35"><font color="#000000">
<br /></font></td>
<td style="border: 1px solid rgb(0, 0, 0);" align="CENTER"><font color="#000000"><a href="http://www.wipo.int/ipcpub/#refresh=page&amp;notion=scheme&amp;version=20110101&amp;symbol=A61K&amp;lang=fr">A61K</a></font></td>
<td style="border: 1px solid rgb(0, 0, 0);" colspan="5" align="CENTER" valign="TOP"><font color="#000000">PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES </font></td>
</tr>
<tr>
<td style="border: 1px solid rgb(0, 0, 0);" align="CENTER" height="35"><font color="#000000">
<br /></font></td>
<td style="border: 1px solid rgb(0, 0, 0);" align="CENTER"><font color="#000000">
<br /></font></td>
<td style="border: 1px solid rgb(0, 0, 0);" align="CENTER"><font color="#000000"><a href="http://www.wipo.int/ipcpub/#refresh=page&amp;notion=scheme&amp;version=20110101&amp;symbol=A61K0035000000&amp;lang=fr">35/00</a></font></td>
<td style="border: 1px solid rgb(0, 0, 0);" colspan="4" align="LEFT" valign="TOP"><font color="#000000">Medicinal preparations containing material or reaction products thereof with undetermined constitution</font></td>
</tr>
<tr>
<td style="border: 1px solid rgb(0, 0, 0);" align="CENTER" height="35"><font color="#000000">
<br /></font></td>
<td style="border: 1px solid rgb(0, 0, 0);" align="CENTER"><font color="#000000">
<br /></font></td>
<td style="border: 1px solid rgb(0, 0, 0);" align="CENTER"><font color="#000000">
<br /></font></td>
<td style="border: 1px solid rgb(0, 0, 0);" align="CENTER"><font color="#000000"><a href="http://www.wipo.int/ipcpub/#refresh=symbol&amp;notion=scheme&amp;version=20110101&amp;symbol=A61K0035360000&amp;lang=fr">35/36</a></font></td>
<td style="border: 1px solid rgb(0, 0, 0);" colspan="3" align="LEFT" valign="TOP"><font color="#000000">Skin; Hair; Nails; Sebaceous glands; Cerumen </font></td>
</tr>
<tr>
<td style="border: 1px solid rgb(0, 0, 0);" align="CENTER" height="35"><font color="#000000">
<br /></font></td>
<td style="border: 1px solid rgb(0, 0, 0);" align="CENTER"><font color="#000000">
<br /></font></td>
<td style="border: 1px solid rgb(0, 0, 0);" align="CENTER"><font color="#000000"><a href="http://www.wipo.int/ipcpub/#refresh=symbol&amp;notion=scheme&amp;version=20110101&amp;symbol=A61K0031000000&amp;lang=fr">31/00</a></font></td>
<td style="border: 1px solid rgb(0, 0, 0);" colspan="4" align="LEFT" valign="TOP"><font color="#000000">Medicinal preparations containing organic active ingredients</font></td>
</tr>
<tr>
<td style="border: 1px solid rgb(0, 0, 0);" align="CENTER" height="35"><font color="#000000">
<br /></font></td>
<td style="border: 1px solid rgb(0, 0, 0);" align="CENTER"><font color="#000000">
<br /></font></td>
<td style="border: 1px solid rgb(0, 0, 0);" align="CENTER"><font color="#000000">
<br /></font></td>
<td style="border: 1px solid rgb(0, 0, 0);" align="CENTER"><font color="#000000"><a href="http://www.wipo.int/ipcpub/#refresh=symbol&amp;notion=scheme&amp;version=20110101&amp;symbol=A61K00315050008/">31/505</a></font></td>
<td style="border: 1px solid rgb(0, 0, 0);" colspan="3" align="LEFT" valign="TOP"><font color="#000000">Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim</font></td>
</tr>
<tr>
<td style="border: 1px solid rgb(0, 0, 0);" align="CENTER" height="35"><font color="#000000">
<br /></font></td>
<td style="border: 1px solid rgb(0, 0, 0);" align="CENTER"><font color="#000000">
<br /></font></td>
<td style="border: 1px solid rgb(0, 0, 0);" align="CENTER"><font color="#000000">
<br /></font></td>
<td style="border: 1px solid rgb(0, 0, 0);" align="CENTER"><font color="#000000"><a href="http://www.wipo.int/ipcpub/#refresh=symbol&amp;notion=scheme&amp;version=20110101&amp;symbol=A61K0031496000">31/496</a></font></td>
<td style="border: 1px solid rgb(0, 0, 0);" colspan="3" align="LEFT" valign="TOP"><font color="#000000"> Non-condensed piperazines containing further heterocyclic rings, e.g. rifampin, thiothixene</font></td>
</tr>
<tr>
<td style="border: 1px solid rgb(0, 0, 0);" align="CENTER" height="35"><font color="#000000">
<br /></font></td>
<td style="border: 1px solid rgb(0, 0, 0);" align="CENTER"><font color="#000000">
<br /></font></td>
<td style="border: 1px solid rgb(0, 0, 0);" align="CENTER"><font color="#000000">
<br /></font></td>
<td style="border: 1px solid rgb(0, 0, 0);" align="CENTER"><font color="#000000"><a href="http://www.wipo.int/ipcpub/#refresh=page&amp;notion=scheme&amp;version=20110101&amp;symbol=A61K0031452000c8/">31/452</a></font></td>
<td style="border: 1px solid rgb(0, 0, 0);" colspan="3" align="LEFT" valign="TOP"><font color="#000000">Piperidinium derivatives</font></td>
</tr>
<tr>
<td style="border: 1px solid rgb(0, 0, 0);" align="CENTER" height="35"><font color="#000000">
<br /></font></td>
<td style="border: 1px solid rgb(0, 0, 0);" align="CENTER"><font color="#000000">
<br /></font></td>
<td style="border: 1px solid rgb(0, 0, 0);" align="CENTER"><font color="#000000">
<br /></font></td>
<td style="border: 1px solid rgb(0, 0, 0);" align="CENTER"><font color="#000000"><a href="http://www.wipo.int/ipcpub/#refresh=symbol&amp;notion=scheme&amp;version=20110101&amp;symbol=A61K0031353000">31/353</a></font></td>
<td style="border: 1px solid rgb(0, 0, 0);" colspan="3" align="LEFT" valign="TOP"><font color="#000000">3,4-Dihydrobenzopyrans, e.g. chroman, catechin</font></td>
</tr>
<tr>
<td style="border: 1px solid rgb(0, 0, 0);" align="CENTER" height="35"><font color="#000000">
<br /></font></td>
<td style="border: 1px solid rgb(0, 0, 0);" align="CENTER"><font color="#000000">
<br /></font></td>
<td style="border: 1px solid rgb(0, 0, 0);" align="CENTER"><font color="#000000">
<br /></font></td>
<td style="border: 1px solid rgb(0, 0, 0);" align="CENTER"><font color="#000000"><a href="http://www.wipo.int/ipcpub/#refresh=symbol&amp;notion=scheme&amp;version=20110101&amp;symbol=A61K0031560000">31/56</a></font></td>
<td style="border: 1px solid rgb(0, 0, 0);" colspan="3" align="LEFT" valign="TOP"><font color="#000000"> Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids</font></td>
</tr>
<tr>
<td style="border: 1px solid rgb(0, 0, 0);" align="CENTER" height="35"><font color="#000000">
<br /></font></td>
<td style="border: 1px solid rgb(0, 0, 0);" align="CENTER"><font color="#000000">
<br /></font></td>
<td style="border: 1px solid rgb(0, 0, 0);" align="CENTER"><font color="#000000">
<br /></font></td>
<td style="border: 1px solid rgb(0, 0, 0);" align="CENTER"><font color="#000000"><a href="http://www.wipo.int/ipcpub/#refresh=symbol&amp;notion=scheme&amp;version=20110101&amp;symbol=A61K0031325000">31/325</a></font></td>
<td style="border: 1px solid rgb(0, 0, 0);" colspan="3" align="LEFT" valign="TOP"><font color="#000000">Carbamic acids; Thiocarbamic acids; Anhydrides or salts thereof </font></td>
</tr>
<tr>
<td style="border: 1px solid rgb(0, 0, 0);" align="CENTER" height="35"><font color="#000000">
<br /></font></td>
<td style="border: 1px solid rgb(0, 0, 0);" align="CENTER"><font color="#000000">
<br /></font></td>
<td style="border: 1px solid rgb(0, 0, 0);" align="CENTER"><font color="#000000">
<br /></font></td>
<td style="border: 1px solid rgb(0, 0, 0);" align="CENTER"><font color="#000000"><a href="http://www.wipo.int/classifications/ipc/ipc8/">31/513</a></font></td>
<td style="border: 1px solid rgb(0, 0, 0);" colspan="3" align="LEFT" valign="TOP"><font color="#000000">having oxo groups directly attached to the heterocyclic ring, e.g. cytosine</font></td>
</tr>
<tr>
<td style="border: 1px solid rgb(0, 0, 0);" align="CENTER" height="35"><font color="#000000">
<br /></font></td>
<td style="border: 1px solid rgb(0, 0, 0);" align="CENTER"><font color="#000000">
<br /></font></td>
<td style="border: 1px solid rgb(0, 0, 0);" align="CENTER"><font color="#000000">
<br /></font></td>
<td style="border: 1px solid rgb(0, 0, 0);" align="CENTER"><font color="#000000"><a href="http://www.wipo.int/ipcpub/#refresh=symbol&amp;notion=scheme&amp;version=20110101&amp;symbol=A61K0031557000">31/557</a></font></td>
<td style="border: 1px solid rgb(0, 0, 0);" colspan="3" align="LEFT" valign="TOP"><font color="#000000">Eicosanoids, e.g. leukotrienes</font></td>
</tr>
<tr>
<td style="border: 1px solid rgb(0, 0, 0);" align="CENTER" height="35"><font color="#000000">
<br /></font></td>
<td style="border: 1px solid rgb(0, 0, 0);" align="CENTER"><font color="#000000">
<br /></font></td>
<td style="border: 1px solid rgb(0, 0, 0);" align="CENTER"><font color="#000000">
<br /></font></td>
<td style="border: 1px solid rgb(0, 0, 0);" align="CENTER"><font color="#000000"><a href="http://www.wipo.int/ipcpub/#refresh=symbol&amp;notion=scheme&amp;version=20110101&amp;symbol=A61K0031570000">31/57</a></font></td>
<td style="border: 1px solid rgb(0, 0, 0);" colspan="3" align="LEFT" valign="TOP"><font color="#000000">substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane, progesterone</font></td>
</tr>
<tr>
<td style="border: 1px solid rgb(0, 0, 0);" align="CENTER" height="35"><font color="#000000">
<br /></font></td>
<td style="border: 1px solid rgb(0, 0, 0);" align="CENTER"><font color="#000000">
<br /></font></td>
<td style="border: 1px solid rgb(0, 0, 0);" align="CENTER"><font color="#000000">
<br /></font></td>
<td style="border: 1px solid rgb(0, 0, 0);" align="CENTER"><font color="#000000"><a href="http://www.wipo.int/ipcpub/#refresh=symbol&amp;notion=scheme&amp;version=20110101&amp;symbol=A61K0031355000">31/355</a></font></td>
<td style="border: 1px solid rgb(0, 0, 0);" colspan="3" align="LEFT" valign="TOP"><font color="#000000">Tocopherols, e.g. vitamin E</font></td>
</tr>
<tr>
<td style="border: 1px solid rgb(0, 0, 0);" align="CENTER" height="35"><font color="#000000">
<br /></font></td>
<td style="border: 1px solid rgb(0, 0, 0);" align="CENTER"><font color="#000000">
<br /></font></td>
<td style="border: 1px solid rgb(0, 0, 0);" align="CENTER"><font color="#000000">
<br /></font></td>
<td style="border: 1px solid rgb(0, 0, 0);" align="CENTER"><font color="#000000"><a href="http://www.wipo.int/ipcpub/#refresh=symbol&amp;notion=scheme&amp;version=20110101&amp;symbol=A61K0031600000">31/60</a></font></td>
<td style="border: 1px solid rgb(0, 0, 0);" colspan="3" align="LEFT" valign="TOP"><font color="#000000">Salicylic acid; Derivatives thereof</font></td>
</tr>
<tr>
<td style="border: 1px solid rgb(0, 0, 0);" align="CENTER" height="35"><font color="#000000">
<br /></font></td>
<td style="border: 1px solid rgb(0, 0, 0);" align="CENTER"><font color="#000000">
<br /></font></td>
<td style="border: 1px solid rgb(0, 0, 0);" align="CENTER"><font color="#000000"><a href="http://www.wipo.int/ipcpub/#refresh=symbol&amp;notion=scheme&amp;version=20110101&amp;symbol=A61K0008000000&amp;lang=fr">08/00</a></font></td>
<td style="border: 1px solid rgb(0, 0, 0);" colspan="4" align="LEFT" valign="TOP"><font color="#000000">Cosmetics or similar toilet preparations</font></td>
</tr>
<tr>
<td style="border: 1px solid rgb(0, 0, 0);" align="CENTER" height="35"><font color="#000000">
<br /></font></td>
<td style="border: 1px solid rgb(0, 0, 0);" align="CENTER"><font color="#000000">
<br /></font></td>
<td style="border: 1px solid rgb(0, 0, 0);" align="CENTER"><font color="#000000">
<br /></font></td>
<td style="border: 1px solid rgb(0, 0, 0);" align="CENTER"><font color="#000000"><a href="http://www.wipo.int/ipcpub/#refresh=symbol&amp;notion=scheme&amp;version=20110101&amp;symbol=A61K0008490000&amp;lang=fr">08/49</a></font></td>
<td style="border: 1px solid rgb(0, 0, 0);" colspan="3" align="LEFT" valign="TOP"><font color="#000000">containing heterocyclic compounds </font></td>
</tr>
<tr>
<td style="border: 1px solid rgb(0, 0, 0);" align="CENTER" bgcolor="#99ccff" height="31"><font color="#000000"><a href="http://www.wipo.int/ipcpub/#refresh=page&amp;notion=scheme&amp;version=20110101&amp;symbol=C07&amp;lang=fr">C07</a></font></td>
<td style="border: 1px solid rgb(0, 0, 0);" colspan="6" align="CENTER" bgcolor="#99ccff"><font color="#000000">ORGANIC CHEMISTRY</font></td>
</tr>
<tr>
<td style="border: 1px solid rgb(0, 0, 0);" align="CENTER" height="31"><font color="#000000">
<br /></font></td>
<td style="border: 1px solid rgb(0, 0, 0);" align="CENTER"><font color="#000000"><a href="http://www.wipo.int/ipcpub/#refresh=page&amp;notion=scheme&amp;version=20110101&amp;symbol=C07H&amp;lang=fr">C07H</a></font></td>
<td style="border: 1px solid rgb(0, 0, 0);" colspan="5" align="CENTER" valign="TOP"><font color="#000000">SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS </font></td>
</tr>
<tr>
<td style="border: 1px solid rgb(0, 0, 0);" align="CENTER" height="35"><font color="#000000">
<br /></font></td>
<td style="border: 1px solid rgb(0, 0, 0);" align="CENTER"><font color="#000000">
<br /></font></td>
<td style="border: 1px solid rgb(0, 0, 0);" align="CENTER"><font color="#000000"><a href="http://www.wipo.int/ipcpub/#refresh=symbol&amp;notion=scheme&amp;version=20110101&amp;symbol=C07H0019000000&amp;lang=fr">19/00</a></font></td>
<td style="border: 1px solid rgb(0, 0, 0);" colspan="4" align="LEFT" valign="TOP"><font color="#000000">Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro derivatives thereof</font></td>
</tr>
<tr>
<td style="border: 1px solid rgb(0, 0, 0);" align="CENTER" height="26"><font color="#000000">
<br /></font></td>
<td style="border: 1px solid rgb(0, 0, 0);" align="CENTER"><font color="#000000">
<br /></font></td>
<td style="border: 1px solid rgb(0, 0, 0);" align="CENTER"><font color="#000000">
<br /></font></td>
<td style="border: 1px solid rgb(0, 0, 0);" align="CENTER" bgcolor="#ffffff"><font color="#000000"><a href="http://www.wipo.int/ipcpub/#refresh=symbol&amp;notion=scheme&amp;version=20110101&amp;symbol=C07H0019060000&amp;lang=fr">19/06</a></font></td>
<td style="border: 1px solid rgb(0, 0, 0);" colspan="3" align="LEFT" valign="TOP"><font color="#000000">Pyrimidine radicals</font></td>
</tr>
<tr>
<td style="border: 1px solid rgb(0, 0, 0);" align="CENTER" height="26"><font color="#000000">
<br /></font></td>
<td style="border: 1px solid rgb(0, 0, 0);" align="CENTER"><font color="#000000"><a href="http://www.wipo.int/ipcpub/#refresh=page&amp;notion=scheme&amp;version=20110101&amp;symbol=C07D&amp;lang=fr">C07D</a></font></td>
<td style="border: 1px solid rgb(0, 0, 0);" colspan="5" align="CENTER" valign="MIDDLE"><font color="#000000">COMPOSÉS HÉTÉROCYCLIQUES</font></td>
</tr>
<tr>
<td style="border: 1px solid rgb(0, 0, 0);" align="CENTER" height="35"><font color="#000000">
<br /></font></td>
<td style="border: 1px solid rgb(0, 0, 0);" align="CENTER"><font color="#000000">
<br /></font></td>
<td style="border: 1px solid rgb(0, 0, 0);" align="CENTER"><font color="#000000"><a href="http://www.wipo.int/ipcpub/#refresh=symbol&amp;notion=scheme&amp;version=20110101&amp;symbol=C07D0415000000&amp;lang=fr">415/00</a></font></td>
<td style="border: 1px solid rgb(0, 0, 0);" colspan="4" align="LEFT" valign="TOP"><font color="#000000">Heterocyclic compounds containing the thiamine skeleton</font></td>
</tr>
<tr>
<td style="border: 1px solid rgb(0, 0, 0);" align="CENTER" height="35"><font color="#000000">
<br /></font></td>
<td style="border: 1px solid rgb(0, 0, 0);" align="CENTER"><font color="#000000">
<br /></font></td>
<td style="border: 1px solid rgb(0, 0, 0);" align="CENTER" valign="MIDDLE"><font color="#000000"><a href="http://www.wipo.int/ipcpub/#refresh=symbol&amp;notion=scheme&amp;version=20110101&amp;symbol=C07D0417020000&amp;lang=fr">417/02</a></font></td>
<td style="border: 1px solid rgb(0, 0, 0);" colspan="4" align="CENTER" valign="MIDDLE"><font color="#000000">containing two hetero rings </font></td>
</tr>
<tr>
<td style="border: 1px solid rgb(0, 0, 0);" align="CENTER" height="35"><font color="#000000">
<br /></font></td>
<td style="border: 1px solid rgb(0, 0, 0);" align="CENTER"><font color="#000000">
<br /></font></td>
<td style="border: 1px solid rgb(0, 0, 0);" align="CENTER"><font color="#000000"><a href="http://www.wipo.int/ipcpub/#refresh=symbol&amp;notion=scheme&amp;version=20110101&amp;symbol=C07D0413000000&amp;lang=fr">413/00</a></font></td>
<td style="border: 1px solid rgb(0, 0, 0);" colspan="4" align="LEFT" valign="TOP"><font color="#000000">Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms [</font></td>
</tr>
<tr>
<td style="border: 1px solid rgb(0, 0, 0);" align="CENTER" height="35"><font color="#000000">
<br /></font></td>
<td style="border: 1px solid rgb(0, 0, 0);" align="CENTER"><font color="#000000">
<br /></font></td>
<td style="border: 1px solid rgb(0, 0, 0);" align="CENTER" valign="MIDDLE"><font color="#000000"><a href="http://www.wipo.int/ipcpub/#refresh=symbol&amp;notion=scheme&amp;version=20110101&amp;symbol=C07D0413020000&amp;lang=fr">413/02</a></font></td>
<td style="border: 1px solid rgb(0, 0, 0);" colspan="4" align="CENTER" valign="MIDDLE"><font color="#000000">containing two hetero rings</font></td>
</tr>
<tr>
<td style="border: 1px solid rgb(0, 0, 0);" align="CENTER" bgcolor="#99ccff" height="31"><font color="#000000"><a href="http://www.wipo.int/ipcpub/#refresh=page&amp;notion=scheme&amp;version=20110101&amp;symbol=C12&amp;lang=fr">C12</a></font></td>
<td style="border: 1px solid rgb(0, 0, 0);" colspan="6" align="CENTER" bgcolor="#99ccff"><font color="#000000">BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING</font></td>
</tr>
<tr>
<td style="border: 1px solid rgb(0, 0, 0);" align="CENTER" height="18"><font color="#000000">
<br /></font></td>
<td style="border: 1px solid rgb(0, 0, 0);" align="CENTER"><font color="#000000"><a href="http://www.wipo.int/ipcpub/#refresh=page&amp;notion=scheme&amp;version=20110101&amp;symbol=C12N&amp;lang=fr">C12N</a></font></td>
<td style="border: 1px solid rgb(0, 0, 0);" colspan="5" align="CENTER" valign="TOP"><font color="#000000">MICRO-ORGANISMS OR ENZYMES; COMPOSITIONS THEREOF</font></td>
</tr>
<tr>
<td style="border: 1px solid rgb(0, 0, 0);" align="CENTER" height="35"><font color="#000000">
<br /></font></td>
<td style="border: 1px solid rgb(0, 0, 0);" align="CENTER"><font color="#000000">
<br /></font></td>
<td style="border: 1px solid rgb(0, 0, 0);" align="CENTER"><font color="#000000"><a href="http://www.wipo.int/ipcpub/#refresh=symbol&amp;notion=scheme&amp;version=20110101&amp;symbol=C12N0005000000&amp;lang=fr">05/00</a></font></td>
<td style="border: 1px solid rgb(0, 0, 0);" colspan="4" align="LEFT" valign="TOP"><font color="#000000">Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor </font></td>
</tr>
<tr>
<td style="border: 1px solid rgb(0, 0, 0);" align="CENTER" height="35"><font color="#000000">
<br /></font></td>
<td style="border: 1px solid rgb(0, 0, 0);" align="CENTER"><font color="#000000">
<br /></font></td>
<td style="border: 1px solid rgb(0, 0, 0);" align="CENTER" valign="MIDDLE"><font color="#000000"><a href="http://www.wipo.int/ipcpub/#refresh=symbol&amp;notion=scheme&amp;version=20110101&amp;symbol=C12N0005071000&amp;lang=fr">05/071</a></font></td>
<td style="border: 1px solid rgb(0, 0, 0);" colspan="4" align="CENTER" valign="MIDDLE"><font color="#000000">Vertebrate cells or tissues, e.g. human cells or tissues</font></td>
</tr>
<tr>
<td style="border: 1px solid rgb(0, 0, 0);" colspan="7" align="CENTER" bgcolor="#99ccff" height="43" valign="MIDDLE"><strong><font color="#000000">US classes and definitions</font></strong></td>
</tr>
<tr>
<td style="border: 1px solid rgb(0, 0, 0);" align="CENTER" bgcolor="#99ccff" height="27" valign="MIDDLE"><font color="#000000"><a href="http://www.uspto.gov/web/patents/classification/uspc424/defs424.htm#C424S074000">424</a></font></td>
<td style="border: 1px solid rgb(0, 0, 0);" colspan="6" align="CENTER" bgcolor="#99ccff" valign="MIDDLE"><font color="#000000">DRUG, BIO-AFFECTING AND BODY TREATING COMPOSITIONS</font></td>
</tr>
<tr>
<td style="border: 1px solid rgb(0, 0, 0);" align="CENTER" bgcolor="#ffffff" height="27" valign="MIDDLE"><font color="#000000">
<br /></font></td>
<td style="border: 1px solid rgb(0, 0, 0);" align="CENTER" bgcolor="#ffffff" valign="MIDDLE"><font color="#000000"><a href="http://www.uspto.gov/web/patents/classification/uspc424/defs424.htm#C424S074000">74</a></font></td>
<td style="border: 1px solid rgb(0, 0, 0);" colspan="5" align="CENTER" valign="TOP"><font color="#000000">Plant extract of undetermined constitution </font></td>
</tr>
<tr>
<td style="border: 1px solid rgb(0, 0, 0);" align="CENTER" height="27"><font color="#000000">
<br /></font></td>
<td style="border: 1px solid rgb(0, 0, 0);" align="CENTER"><font color="#000000"><a href="http://www.uspto.gov/web/patents/classification/uspc424/sched424.htm#C424S728000">728</a></font></td>
<td style="border: 1px solid rgb(0, 0, 0);" colspan="5" align="CENTER" valign="TOP"><font color="#000000">Containing or obtained from Panax or Acanthopanax (e.g., ginseng, etc.) </font></td>
</tr>
<tr>
<td style="border: 1px solid rgb(0, 0, 0);" align="CENTER" height="27"><font color="#000000">
<br /></font></td>
<td style="border: 1px solid rgb(0, 0, 0);" align="CENTER"><font color="#000000"><a href="http://www.uspto.gov/web/patents/classification/uspc424/defs424.htm#C424S770000">770</a></font></td>
<td style="border: 1px solid rgb(0, 0, 0);" colspan="5" align="CENTER" valign="TOP"><font color="#000000">Conifer (e.g., needle and cone bearing trees such as pine, spruce, hemlock, fir, cypress, cedar, yew, etc.) </font></td>
</tr>
<tr>
<td style="border: 1px solid rgb(0, 0, 0);" align="CENTER" height="27"><font color="#000000">
<br /></font></td>
<td style="border: 1px solid rgb(0, 0, 0);" align="CENTER"><font color="#000000"><a href="http://www.uspto.gov/web/patents/classification/uspc424/defs424.htm#C424S770000">778</a></font></td>
<td style="border: 1px solid rgb(0, 0, 0);" colspan="5" align="CENTER" valign="TOP"><font color="#000000">Containing or obtained from a flower or blossom (aka flos) </font></td>
</tr>
<tr>
<td style="border: 1px solid rgb(0, 0, 0);" align="CENTER" height="27"><font color="#000000">
<br /></font></td>
<td style="border: 1px solid rgb(0, 0, 0);" align="CENTER"><font color="#000000"><a href="http://www.uspto.gov/web/patents/classification/uspc424/defs424.htm#C424S401000">401</a></font></td>
<td style="border: 1px solid rgb(0, 0, 0);" colspan="5" align="CENTER" valign="TOP"><font color="#000000"> Cosmetic, antiperspirant, dentifrice </font></td>
</tr>
<tr>
<td style="border: 1px solid rgb(0, 0, 0);" align="CENTER" height="27"><font color="#000000">
<br /></font></td>
<td style="border: 1px solid rgb(0, 0, 0);" align="CENTER"><font color="#000000"><a href="http://www.uspto.gov/web/patents/classification/uspc424/defs424.htm#C424S070100">70.1</a></font></td>
<td style="border: 1px solid rgb(0, 0, 0);" colspan="5" align="CENTER" valign="TOP"><font color="#000000">LIVE HAIR OR SCALP TREATING COMPOSITIONS (NONTHERAPEUTIC) </font></td>
</tr>
<tr>
<td style="border: 1px solid rgb(0, 0, 0);" align="CENTER" height="27"><font color="#000000">
<br /></font></td>
<td style="border: 1px solid rgb(0, 0, 0);" align="CENTER"><font color="#000000"><a href="http://www.uspto.gov/web/patents/classification/uspc424/defs424.htm#C424S728000">728</a></font></td>
<td style="border: 1px solid rgb(0, 0, 0);" colspan="5" align="CENTER" valign="TOP"><font color="#000000"> Containing or obtained from Panax or Acanthopanax (e.g., ginseng, etc.) </font></td>
</tr>
<tr>
<td style="border: 1px solid rgb(0, 0, 0);" align="CENTER" bgcolor="#99ccff" height="33"><font color="#000000"><a href="http://www.uspto.gov/web/patents/classification/uspc514/defs514.htm#C514S254110">514</a></font></td>
<td style="border: 1px solid rgb(0, 0, 0);" colspan="6" align="CENTER" bgcolor="#99ccff" valign="MIDDLE"><font color="#000000">DRUG, BIO-AFFECTING AND BODY TREATING COMPOSITIONS</font></td>
</tr>
<tr>
<td style="border: 1px solid rgb(0, 0, 0);" align="CENTER" height="27"><font color="#000000">
<br /></font></td>
<td style="border: 1px solid rgb(0, 0, 0);" align="CENTER"><font color="#000000"><a href="http://www.uspto.gov/web/patents/classification/uspc514/defs514.htm#C514S254110">254.11</a></font></td>
<td style="border: 1px solid rgb(0, 0, 0);" colspan="5" align="CENTER" valign="TOP"><font color="#000000">Polycyclo ring system having the additional oxygen hetero ring as one of the cyclos </font></td>
</tr>
<tr>
<td style="border: 1px solid rgb(0, 0, 0);" align="CENTER" height="27"><font color="#000000">
<br /></font></td>
<td style="border: 1px solid rgb(0, 0, 0);" align="CENTER"><font color="#000000"><a href="http://www.uspto.gov/web/patents/classification/uspc514/defs514.htm#C514S254110">320</a></font></td>
<td style="border: 1px solid rgb(0, 0, 0);" colspan="5" align="CENTER" valign="TOP"><font color="#000000"> Hetero ring in the polycyclo ring system </font></td>
</tr>
<tr>
<td style="border: 1px solid rgb(0, 0, 0);" align="CENTER" height="27"><font color="#000000">
<br /></font></td>
<td style="border: 1px solid rgb(0, 0, 0);" align="CENTER"><font color="#000000"><a href="http://www.uspto.gov/web/patents/classification/uspc514/defs514.htm#C514S254110">456</a></font></td>
<td style="border: 1px solid rgb(0, 0, 0);" colspan="5" align="CENTER" valign="TOP"><font color="#000000">Bicyclo ring system having the hetero ring as one of the cyclos (e.g., chromones, etc.) </font></td>
</tr>
<tr>
<td style="border: 1px solid rgb(0, 0, 0);" align="CENTER" height="27"><font color="#000000">
<br /></font></td>
<td style="border: 1px solid rgb(0, 0, 0);" align="CENTER"><font color="#000000"><a href="http://www.uspto.gov/web/patents/classification/uspc514/defs514.htm#C514S254110">169</a></font></td>
<td style="border: 1px solid rgb(0, 0, 0);" colspan="5" align="CENTER" valign="TOP"><font color="#000000">Subclass 169 indent level is 1 Cyclopentanohydrophenanthrene ring system DOAI </font></td>
</tr>
<tr>
<td style="border: 1px solid rgb(0, 0, 0);" align="CENTER" height="27"><font color="#000000">
<br /></font></td>
<td style="border: 1px solid rgb(0, 0, 0);" align="CENTER"><font color="#000000"><a href="http://www.uspto.gov/web/patents/classification/uspc514/defs514.htm#C514S254110">485</a></font></td>
<td style="border: 1px solid rgb(0, 0, 0);" colspan="5" align="CENTER" valign="TOP"><font color="#000000"> The ring is a benzene ring </font></td>
</tr>
<tr>
<td style="border: 1px solid rgb(0, 0, 0);" align="CENTER" height="27"><font color="#000000">
<br /></font></td>
<td style="border: 1px solid rgb(0, 0, 0);" align="CENTER"><font color="#000000"><a href="http://www.uspto.gov/web/patents/classification/uspc514/defs514.htm#C514S254110">171</a></font></td>
<td style="border: 1px solid rgb(0, 0, 0);" colspan="5" align="CENTER" valign="TOP"><font color="#000000">With additional active ingredient </font></td>
</tr>
<tr>
<td style="border: 1px solid rgb(0, 0, 0);" align="CENTER" height="27"><font color="#000000">
<br /></font></td>
<td style="border: 1px solid rgb(0, 0, 0);" align="CENTER"><font color="#000000"><a href="http://www.uspto.gov/web/patents/classification/uspc514/defs514.htm#C514S254110">227.8</a></font></td>
<td style="border: 1px solid rgb(0, 0, 0);" colspan="5" align="CENTER" valign="TOP"><font color="#000000"> Additional hetero ring attached directly or indirectly to the 1,4-thiazine by nonionic bonding </font></td>
</tr>
<tr>
<td style="border: 1px solid rgb(0, 0, 0);" align="CENTER" height="27"><font color="#000000">
<br /></font></td>
<td style="border: 1px solid rgb(0, 0, 0);" align="CENTER"><font color="#000000"><a href="http://www.uspto.gov/web/patents/classification/uspc514/defs514.htm#C514S254110">232.5</a></font></td>
<td style="border: 1px solid rgb(0, 0, 0);" colspan="5" align="CENTER" valign="TOP"><font color="#000000"> Polycyclo ring system having the additional hetero ring as one of the cyclos </font></td>
</tr>
<tr>
<td style="border: 1px solid rgb(0, 0, 0);" align="CENTER" height="27"><font color="#000000">
<br /></font></td>
<td style="border: 1px solid rgb(0, 0, 0);" align="CENTER"><font color="#000000"><a href="http://www.uspto.gov/web/patents/classification/uspc514/defs514.htm#C514S254110">253.07</a></font></td>
<td style="border: 1px solid rgb(0, 0, 0);" colspan="5" align="CENTER" valign="TOP"><font color="#000000"> Chalcogen bonded directly to carbon of the hetero ring of the quinoline ring system </font></td>
</tr>
<tr>
<td style="border: 1px solid rgb(0, 0, 0);" align="CENTER" height="27"><font color="#000000">
<br /></font></td>
<td style="border: 1px solid rgb(0, 0, 0);" align="CENTER"><font color="#000000"><a href="http://www.uspto.gov/web/patents/classification/uspc514/defs514.htm#C514S254110">254.11</a></font></td>
<td style="border: 1px solid rgb(0, 0, 0);" colspan="5" align="CENTER" valign="TOP"><font color="#000000"> Polycyclo ring system having the additional oxygen hetero ring as one of the cyclos </font></td>
</tr>
<tr>
<td style="border: 1px solid rgb(0, 0, 0);" align="CENTER" height="27"><font color="#000000">
<br /></font></td>
<td style="border: 1px solid rgb(0, 0, 0);" align="CENTER"><font color="#000000"><a href="http://www.uspto.gov/web/patents/classification/uspc514/defs514.htm#C514S254110">312</a></font></td>
<td style="border: 1px solid rgb(0, 0, 0);" colspan="5" align="CENTER" valign="TOP"><font color="#000000">Chalcogen attached directly to the six-membered hetero ring by nonionic bonding </font></td>
</tr>
<tr>
<td style="border: 1px solid rgb(0, 0, 0);" align="CENTER" height="27"><font color="#000000">
<br /></font></td>
<td style="border: 1px solid rgb(0, 0, 0);" align="CENTER"><font color="#000000"><a href="http://www.uspto.gov/web/patents/classification/uspc514/defs514.htm#C514S254110">320</a></font></td>
<td style="border: 1px solid rgb(0, 0, 0);" colspan="5" align="CENTER" valign="TOP"><font color="#000000"> Hetero ring in the polycyclo ring system </font></td>
</tr>
<tr>
<td style="border: 1px solid rgb(0, 0, 0);" align="CENTER" height="27"><font color="#000000">
<br /></font></td>
<td style="border: 1px solid rgb(0, 0, 0);" align="CENTER"><font color="#000000"><a href="http://www.uspto.gov/web/patents/classification/uspc514/defs514.htm#C514S254110">269</a></font></td>
<td style="border: 1px solid rgb(0, 0, 0);" colspan="5" align="CENTER" valign="TOP"><font color="#000000">Pyrimidines with chalcogen bonded directly to a ring carbon of said pyrimidine moiety </font></td>
</tr>
<tr>
<td style="border: 1px solid rgb(0, 0, 0);" align="CENTER" height="27"><font color="#000000">
<br /></font></td>
<td style="border: 1px solid rgb(0, 0, 0);" align="CENTER"><font color="#000000"><a href="http://www.uspto.gov/web/patents/classification/uspc514/defs514.htm#C514S254110">573</a></font></td>
<td style="border: 1px solid rgb(0, 0, 0);" colspan="5" align="CENTER" valign="TOP"><font color="#000000">Cyclopentyl or cyclopentene (e.g., prostaglandins, etc.) </font></td>
</tr>
<tr>
<td style="border: 1px solid rgb(0, 0, 0);" align="CENTER" height="27"><font color="#000000">
<br /></font></td>
<td style="border: 1px solid rgb(0, 0, 0);" align="CENTER"><font color="#000000"><a href="http://www.uspto.gov/web/patents/classification/uspc514/defs514.htm#C514S254110">159</a></font></td>
<td style="border: 1px solid rgb(0, 0, 0);" colspan="5" align="CENTER" valign="TOP"><font color="#000000"> Ortho-hydroxybenzoic acid (i.e., salicyclic acid) or derivative DOAI </font></td>
</tr>
<tr>
<td style="border: 1px solid rgb(0, 0, 0);" align="CENTER" height="27"><font color="#000000">
<br /></font></td>
<td style="border: 1px solid rgb(0, 0, 0);" align="CENTER"><font color="#000000"><a href="http://www.uspto.gov/web/patents/classification/uspc514/defs514.htm#C514S254110">458</a></font></td>
<td style="border: 1px solid rgb(0, 0, 0);" colspan="5" align="CENTER" valign="TOP"><font color="#000000">Tocopherols (e.g., vitamin E, etc.) </font></td>
</tr>
<tr>
<td style="border: 1px solid rgb(0, 0, 0);" align="CENTER" bgcolor="#99ccff" height="32"><font color="#000000"><a href="http://www.uspto.gov/web/patents/classification/uspc544/defs544.htm#C544S126000">544</a></font></td>
<td style="border: 1px solid rgb(0, 0, 0);" colspan="6" align="CENTER" bgcolor="#99ccff" valign="MIDDLE"><font color="#000000">ORGANIC COMPOUNDS -- PART OF THE CLASS 532-570 SERIES</font></td>
</tr>
<tr>
<td style="border: 1px solid rgb(0, 0, 0);" align="CENTER" height="23"><font color="#000000">
<br /></font></td>
<td style="border: 1px solid rgb(0, 0, 0);" align="CENTER"><font color="#000000"><a href="http://www.uspto.gov/web/patents/classification/uspc544/defs544.htm#C544S126000">126</a></font></td>
<td style="border: 1px solid rgb(0, 0, 0);" colspan="5" align="CENTER" valign="TOP"><font color="#000000">The additional six-membered hetero ring is one of the cyclos in a tricyclo ring system </font></td>
</tr>
<tr>
<td style="border: 1px solid rgb(0, 0, 0);" align="CENTER" height="26"><font color="#000000">
<br /></font></td>
<td style="border: 1px solid rgb(0, 0, 0);" align="CENTER"><font color="#000000"><a href="http://www.uspto.gov/web/patents/classification/uspc544/defs544.htm#C544S126000">363</a></font></td>
<td style="border: 1px solid rgb(0, 0, 0);" colspan="5" align="CENTER" valign="TOP"><font color="#000000">Quinoline or isoquinoline (including hydrogenated) </font></td>
</tr>
<tr>
<td style="border: 1px solid rgb(0, 0, 0);" align="CENTER" height="27"><font color="#000000">
<br /></font></td>
<td style="border: 1px solid rgb(0, 0, 0);" align="CENTER"><font color="#000000"><a href="http://www.uspto.gov/web/patents/classification/uspc544/defs544.htm#C544S126000">60</a></font></td>
<td style="border: 1px solid rgb(0, 0, 0);" colspan="5" align="CENTER" valign="TOP"><font color="#000000">Additional hetero ring containing </font></td>
</tr>
<tr>
<td style="border: 1px solid rgb(0, 0, 0);" align="CENTER" bgcolor="#99ccff" height="32"><font color="#000000"><a href="http://www.uspto.gov/web/patents/classification/uspc546/defs546.htm#C546S157000">546</a></font></td>
<td style="border: 1px solid rgb(0, 0, 0);" colspan="6" align="CENTER" bgcolor="#99ccff" valign="MIDDLE"><font color="#000000">ORGANIC COMPOUNDS -- PART OF THE CLASS 532-570 SERIES</font></td>
</tr>
<tr>
<td style="border: 1px solid rgb(0, 0, 0);" align="CENTER" height="17"><font color="#000000">
<br /></font></td>
<td style="border: 1px solid rgb(0, 0, 0);" align="CENTER"><font color="#000000"><a href="http://www.uspto.gov/web/patents/classification/uspc546/defs546.htm#C546S157000">157</a></font></td>
<td style="border: 1px solid rgb(0, 0, 0);" colspan="5" align="CENTER" valign="TOP"><font color="#000000"> Chalcogen attached directly at 2-position by nonionic bonding </font></td>
</tr>
<tr>
<td style="border: 1px solid rgb(0, 0, 0);" align="CENTER" height="27"><font color="#000000">
<br /></font></td>
<td style="border: 1px solid rgb(0, 0, 0);" align="CENTER"><font color="#000000"><a href="http://www.uspto.gov/web/patents/classification/uspc546/defs546.htm#C546S157000">198</a></font></td>
<td style="border: 1px solid rgb(0, 0, 0);" colspan="5" align="CENTER" valign="TOP"><font color="#000000">Ring nitrogen in the polycyclo ring system </font></td>
</tr> </tbody>
</table>&nbsp;
<br />
</p>
==Thomson Innovation Search==
Crazypaddu
326
edits
Retrieved from "https://www.dolcera.com/wiki/index.php?title=Special:MobileDiff/7849...7850"